Publications

2025

Makangara-Cigolo JC et al., Clade Ia Monkeypox Virus Linked to Sexual Transmission, Democratic Republic of the Congo, August 2024 (Emerging Infectious Diseases)

Lemaille C. et al., Assessing mpox knowledge and sexual behaviours within high-risk populations in the Democratic Republic of the Congo. (Preprint)

PALM007 Writing Group, Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo. (NEJM)

Kraseman S. et al., Public health priorities for mpox clade Ib in pregnant, breastfeeding, and paediatric populations in DR Congo (The Lancet Infectious Disease)

Mbala-Kingebeni P. et al., Ocular Manifestations in a Cohort of Patients with Mpox in the Democratic Republic of the Congo 2007 - 2011. (Preprint)

Vakaniaki EH et al., Establishment of a regional Mpox surveillance network in Central Africa: shared experiences in an endemic region (Global Health Research and Policy)

Brosius I. et al., Epidemiological and Clinical Features of Mpox during the Clade Ib outbreak in South-Kivu, Democratic Republic of the Congo: a prospective cohort study. (The Lancet)

Bangwen E et al., Mpox in the Democratic Republic of Congo: Analysis of National Epidemiological and Laboratory Surveillance Data, 2010 - 2023 (The Lancet)

2024

Halbrook M. et al. Mpox in Central Africa: complex epidemiology requires a constellation approach (npj viruses)

Mukadi-Bamuleka D. et al. First imported Cases of MPXV Clade Ib in Goma, Democratic Republic of the Congo: Implications for Global Surveillance and Transmission Dynamics. (Preprint)

Kinganda-Lusamaki E. et al. Clade I mpox virus genomic diversity in the Democratic Republic of the Congo, 2018-2024: Predominance of zoonotic transmission. Cell. 2024 Oct 24:S0092-8674(24)01199-1

Nizigiuimana A. et al. Epidemiological analysis of confirmed mpox cases, Burundi, 3 July to 9 September 2024.

Euro Surveill. 2024 Oct;29(42):2400647

Vakaniaki EH et al. Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo.  Nat Med. 2024 Oct;30(10):2791-2795

Vakaniaki EH et al. Presumed Transmission of 2 Distinct Monkeypox Virus Variants from Central African Republic to Democratic Republic of the Congo. Emerg Infect Dis. 2024 Oct;30(10):2128-2134

Mbala-Kingebeni P et al. The time is now (again) for mpox containment and elimination in Democratic Republic of the Congo. PLOS Glob Public Health. 2024 Jun 7;4(6):e0003171

Komakech A et al. Africa should research the long-term sequelae of mpox. Lancet Glob Health. 2024 Oct;12(10):e1580-e1581

Nachega et al. The surge of mpox in Africa: a call for action.

Lancet Glob Health. 2024 Jul;12(7):e1086-e1088

Wawima-Bokalanga T et al. Co-circulation of monkeypox virus subclades Ia and Ib in Kinshasa Province, Democratic Republic of the Congo, July to August 2024. Euro Surveill. 2024 Sep;29(38):2400592.

Kalonji T et al. Co-Circulating Monkeypox and Swinepox Viruses, Democratic Republic of the Congo, 2022. 

Emerg Infect Dis. 2024 Apr;30(4):761-765.

2023

Van Dijck C et al. Emergence of mpox in the post-smallpox era-a narrative review on mpox epidemiology. Clin Microbiol Infect. 2023;29(12):1487-1492.

Nachega JB et al. The Human Mpox Global Outbreak: Available Control Tools and the Opportunity to Break a Cycle of Neglect in Endemic Countries. Am J Trop Med Hyg. 2023 Aug 14;109(4):719-724

Mitjà et al. Mpox in people with advanced HIV infection: a global case series.

Lancet. 2023 Mar 18;401(10380):939-949. 

Van Dijck C et al. Beware of drug resistance: Let’s not lose tecovirimat against mpox.

Clin Microbiol Infect. 2024 Mar;30(3):276-278

Mertes H et al. Tecovirimat Resistance in an Immunocompromised Patient With Mpox and Prolonged Viral Shedding. Ann Intern Med. 2023 Aug;176(8):1141-1143

Nachega JB et al. The Human Mpox Global Outbreak: Available Control Tools and the Opportunity to Break a Cycle of Neglect in Endemic Countries. Am J Trop Med Hyg. 2023 Aug 14;109(4):719-724